HomeInsightsMarket Capitalization

Market Capitalization of Indoco Remedies Ltd

Market Capitalization of Indoco Remedies Ltd

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 29, 2024)

stocks purchased

2.0 K

Stocks Traded

(Nov 29, 2024)

Last Updated on: Nov 30, 2024

Image

Indoco Remedies Ltd

NSE: INDOCO

Market Cap

₹ 2994.54 crore

Last updated on: Nov 29, 2024

Key Highlights

  • The Market Cap of Indoco Remedies Ltd is ₹ 2994 crore as of 29 Nov 24 .
  • The Market Cap of Indoco Remedies Ltd changed from ₹ 1867 crore on March 2019 to ₹ 3027 crore on March 2024 . This represents a CAGR of 8.38% over 6 years.
  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 324.85 as of 29 Nov 15:30 .
  • The dividend payouts of Indoco Remedies Ltd changed from ₹ 0.3 to ₹ 1.5 over 6 quarters. This represents a CAGR of 192.40% .

Historical Market Cap of Indoco Remedies Ltd

No data available

* All values are in crore

Company Fundamentals for Indoco Remedies Ltd

No data available

Image

Indoco Remedies Ltd

NSE: INDOCO

Share Price

₹ 324.85

9.65 (3.06%)

stock direction

Last updated on: Nov 29, 2024

Market Price of Indoco Remedies Ltd

1M

1Y

3Y

5Y

Monitoring Indoco Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Nov 2024324.85
28 Nov 2024315.2
27 Nov 2024305.35
26 Nov 2024315.95
25 Nov 2024322.05
22 Nov 2024320
21 Nov 2024299.85
19 Nov 2024304.3
18 Nov 2024307.4
14 Nov 2024309.15

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Indoco Remedies Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Indoco Remedies Ltd

No data available

No data available

Historical P/E Ratio of Indoco Remedies Ltd

No data available

* All values are in %

Historical Revenue of Indoco Remedies Ltd

No data available

* All values are in crore

Historical EBITDA of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Indoco Remedies Ltd

No data available

* All values are in

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

Indoco Remedies Ltd News Hub

News

Indoco Remedies slides as Q2 PAT tumbles 61% YoY to Rs 13 cr

Revenue from operations decreased by 15.18% year on year (YoY) to Rs 394.58 crore in the q...

Read more

24 Oct 202415:21

News

Indoco Remedies to convene board meeting

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 24 October...

Read more

15 Oct 202410:33

News

Indoco Remedies' Goa plant classified as OAI by US FDA

In a regulatory filing made after market hours on Friday, the pharmaceutical company infor...

Read more

14 Oct 202409:28

News

Indoco Remedies update on USFDA inspection of its facilities in Goa

Indoco Remedies has received regulatory status from U.S. Food and Drug Administration (USF...

Read more

11 Oct 202419:10

News

Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets

Indoco Remedies (Indoco) announced the receipt of final approval from the USFDA for Abbrev...

Read more

04 Oct 202414:26

News

Indoco Remedies AGM scheduled

Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

31 Aug 202416:28

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Indoco Remedies Ltd Market Cap

What is the market cap of Indoco Remedies Ltd?

As of November 30, 2024, Indoco Remedies Ltd has a market capitalization of ₹2994.54, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Indoco Remedies Ltd's market capitalization?

Indoco Remedies Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Indoco Remedies Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Indoco Remedies Ltd's market capitalization change?

Indoco Remedies Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading starting at just

Rs. 249*